SH UCL Translational Research Office Related Content
Galvanising the scientific community towards a common goal during a pandemic
Jane Kinghorn, Director at UCL Translational Research Office and Nick McNally, Managing Director Research UCL/UCLH, describe some of the approaches taken by the scientific community in supporting hospitals dealing with the COVID-19 pandemic.
Partnerships are key to biomedical translational success
Jane Kinghorn, Director at UCL Translational Research Office and Anne Lane, CEO at UCL Business Ltd describe the contributing factors to the success of accelerating biomedical therapeutic translation at UCL and their partner hospitals.
Industrial partnership with university leads research on alternative dental filling material
Case study: UCL researchers and dental materials manufacturer collaborate to speed up the development of a new dental filling material for children.
Academia: An important player in the drug discovery ecosystem
Dr Richard Angell and Dr Jane Kinghorn from the Drug Discovery Group (Translational Research Office), at University College London (UCL), explain the value of drug discovery in academia in bridging the “Valley of Death”.
UCL: A global partner for health research & innovation
Jane Kinghorn, along with Marta Ribeiro, Felipe Fouto, and Colby Benari from UCL, argues that the ability to listen and learn makes UCL a global partner of choice for health research & innovation.
Delivering improved health and wealth in the UK
Jane Kinghorn, Director of the Translational Research Office at UCL, discusses the importance of research and partnership in improving the health and wealth of the UK.
